These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 19289504)
1. Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation. Yim H; Erikson RL Mol Cell Biol; 2009 May; 29(10):2609-21. PubMed ID: 19289504 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation. Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154 [TBL] [Abstract][Full Text] [Related]
3. Normal cells, but not cancer cells, survive severe Plk1 depletion. Liu X; Lei M; Erikson RL Mol Cell Biol; 2006 Mar; 26(6):2093-108. PubMed ID: 16507989 [TBL] [Abstract][Full Text] [Related]
4. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Kreis NN; Sommer K; Sanhaji M; Krämer A; Matthess Y; Kaufmann M; Strebhardt K; Yuan J Cell Cycle; 2009 Feb; 8(3):460-72. PubMed ID: 19177004 [TBL] [Abstract][Full Text] [Related]
5. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death. Lin YC; Sun SH; Wang FF Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628 [TBL] [Abstract][Full Text] [Related]
6. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage. Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240 [TBL] [Abstract][Full Text] [Related]
7. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Ma HT; Tsang YH; Marxer M; Poon RY Mol Cell Biol; 2009 Dec; 29(24):6500-14. PubMed ID: 19822658 [TBL] [Abstract][Full Text] [Related]
8. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway. Lee HJ; Hwang HI; Jang YJ Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453 [TBL] [Abstract][Full Text] [Related]
10. p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors. Sanhaji M; Kreis NN; Zimmer B; Berg T; Louwen F; Yuan J Cell Cycle; 2012 Feb; 11(3):543-53. PubMed ID: 22262171 [TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. Studach L; Wang WH; Weber G; Tang J; Hullinger RL; Malbrue R; Liu X; Andrisani O J Biol Chem; 2010 Sep; 285(39):30282-93. PubMed ID: 20624918 [TBL] [Abstract][Full Text] [Related]
12. SCF(FBXW7α) modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability. Giráldez S; Herrero-Ruiz J; Mora-Santos M; Japón MÁ; Tortolero M; Romero F Oncotarget; 2014 Jun; 5(12):4370-83. PubMed ID: 24970797 [TBL] [Abstract][Full Text] [Related]
13. Polo-like kinase 1 inhibits DNA damage response during mitosis. Benada J; Burdová K; Lidak T; von Morgen P; Macurek L Cell Cycle; 2015; 14(2):219-31. PubMed ID: 25607646 [TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals. Guan R; Tapang P; Leverson JD; Albert D; Giranda VL; Luo Y Cancer Res; 2005 Apr; 65(7):2698-704. PubMed ID: 15805268 [TBL] [Abstract][Full Text] [Related]
15. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression. Li H; Wang Y; Liu X J Biol Chem; 2008 Mar; 283(10):6209-21. PubMed ID: 18171681 [TBL] [Abstract][Full Text] [Related]
16. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome. Moshe Y; Boulaire J; Pagano M; Hershko A Proc Natl Acad Sci U S A; 2004 May; 101(21):7937-42. PubMed ID: 15148369 [TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53. Sanhaji M; Louwen F; Zimmer B; Kreis NN; Roth S; Yuan J Cell Cycle; 2013 May; 12(9):1340-51. PubMed ID: 23574746 [TBL] [Abstract][Full Text] [Related]
18. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex. Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372 [TBL] [Abstract][Full Text] [Related]